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ABSTRACT
Objective: To report a case of successful long-term conservative management of a patient with aortic graft infection due to multiple infectious 
agents. 
Materials and methods: We describe the clinical case and present a review of relevant literature.
Results: An 82-year-old man presented with recurrent Escherichia coli bacteraemia. He was diagnosed with an endovascular aortic graft 
infection. As the patient declined surgery, conservative treatment with daily antibiotic therapy was instituted. We report good clinical 
results after almost 2 years of treatment and follow-up. 
Conclusions: The preferred treatment of aortic graft infections is surgical. Conservative management is usually offered to poor surgical 
candidates and is associated with an unfavourable outcome. However, we report that selected patients may be successfully treated using 
prolonged antibiotic therapy. 
LEARNING POINTS
• Endovascular graft infection is a serious, potentially life-threatening complication of aortic aneurism repair.
• Surgical management is the preferred therapeutic approach; information about conservative therapy options and their outcomes is 
limited. 
• Long-term conservative management with ambulatory maintenance antibiotic therapy is an adequate treatment alternative and in 
selected patients can lead to a good clinical outcome. 
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INTRODUCTION
The use of endovascular grafts for the treatment of aortic aneurysms has increased significantly. Bacterial infections of these grafts, 
either in the perioperative period or later, are a feared complication with possibly fatal results. Although there are no clear guidelines for 
the management of these infections, antibiotic treatment is less accepted and the surgical approach (i.e. removal of the infected graft) is 
commonly adopted. We describe here a rare case of successful long-term antibiotic treatment of a recurrent graft infection due to multiple 
infectious agents.
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CLINICAL CASE  
An 82-year-old man, whose past medical history includes smoking, hypertension, ischaemic heart disease, dyslipidaemia, benign prostatic 
hyperplasia, cholecystectomy and an abdominal aortic aneurysm treated by graft insertion 10 years previously, was admitted to our 
internal medicine department with recurrent episodes of general weakness, chills and high fever. Blood cultures were consistently 
positive for Escherichia coli. The patient was treated with IV antibiotics with resolution of fever and symptoms. Between the febrile 
episodes related to E. coli bacteraemia, the patient was asymptomatic and repeated blood cultures were negative. An extensive 
diagnostic and imaging work-up including renal US, CT urography, cystoscopy, colonoscopy, echocardiography and magnetic resonance 
cholangiopancreatography (MRCP) did not reveal the source of the recurrent infection. 
However, CT angiography of the abdominal aorta demonstrated signs of aortitis in the area of the graft adjacent to the third part of the 
duodenum with a suspected aorto-enteric fistula. A PET-CT scan detected pathological uptake and wall thickening of the aortic graft 
consistent with infectious aortitis. The patient was offered surgical removal of the infected graft. He declined due to the substantial 
perioperative risk, so chronic daily maintenance treatment with intravenous ceftriaxone was administered via a permanent central 
catheter. More than 20 months have passed since diagnosis. During this period, the patient was admitted four more times with recurrent 
episodes of bacteraemia due to ESBL-positive E. coli and Candida albicans that were successfully treated with ertapenem and fluconazole, 
respectively. The patient continues to feel well under daily antibiotic therapy and to decline surgical treatment.
DISCUSSION
The incidence and prevalence of bacterial infections of endovascular grafts are significant, reaching 3% in different reviews[1]. These numbers 
are expected to grow in view of the preferential employment of these grafts to treat a variety of vascular pathologies[2]. 
Graft infections are associated with a very high rate of mortality, which reaches 56.5%[3]. The most common infectious organisms are Gram-
positive cocci, especially Staphylococcus aureus and Staphylococcus epidermidis, and to a much lesser extent, Gram-negative bacilli and E. coli 
infection, which is particularly rare[1]. The optimal management of prosthetic graft infection is unclear, but the common default approach 
is complete removal of the infected graft[3]. Some patients with very high perioperative risk may undergo full or partial graft preservation 
with instillation or irrigation of local antibiotics or continuous intravenous antibiotic treatment[1,4], although there are no clear guidelines 
regarding conservative non-surgical treatment of these infections and only a handful of reports describe short-term conservative antibiotic 
treatment of endovascular graft infections[5]. As the use of endovascular stent grafting is becoming widespread, there is a growing need to 
deal with the complications of this procedure, namely infections. This is particularly true as patients undergoing this treatment are older 
and have a greater burden of chronic diseases[2]. Therefore, many patients are not candidates for the preferred surgical treatment or refuse 
it altogether, like our patient. Thus, the long-term clinical stability achieved in our patient with chronic ambulatory maintenance antibiotic 
therapy provides a practical and efficient therapeutic modality which may be adopted in a growing number of similar patients. 
Future studies comparing surgical and conservative management of infected endovascular grafts are needed to determine which of these 
approaches is best in a particular patient. 
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